Analyst Price Target is $0.00
This price target is based on 3 analysts offering 12 month price targets for Revenio Group Oyj in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a NaN upside from the last price of $0.00.
Current Consensus is
The current consensus among 3 contributing investment analysts is to buy stock in Revenio Group Oyj. This rating has held steady since March 2021, when it changed from a Hold consensus rating.
Revenio Group Oyj is a globally operating health technology, which engages in the detection of glaucoma, osteoporosis, skin cancer, and asthma. It operates through the Revenio Health Tech segment, which designs, manufactures, and sales tonometers and bone density measurement devices. The company is headquartered in Vantaa, Finland.